Filing Flows

Filing Flows › Aquestive Therapeutics (AQST) › Who owns the stock

Who owns Aquestive Therapeutics (AQST) stock

167 funds reported Aquestive Therapeutics (AQST) shares in their latest 13F filings, worth $327M in all. The largest holder is Bratton Capital Management, L.P. ($45.4M). Last quarter 84 funds added to their stakes and 55 cut them.

Largest holders of AQST (13F)Largest holders of AQST (13F)Bratton Capital Management, L.P.$45.4MVanguard Group$38.1MBlackRock$33.6MRTW Investments, LP$30.9MVanguard Capital Management LLC$19.1MFederated Hermes$12.9MState Street$12.2MGeode Capital Management, LLC$10.9MSamsara BioCapital, LLC$10.4MBank of America$6.9M

Largest holders (13F)

FundSharesValueChangeQuarter
Bratton Capital Management, L.P.9,810,958$45.4Munchanged2026-09-30
Vanguard Group5,892,334$38.1Mincrease2025-12-31
BlackRock8,069,373$33.6Mincrease2026-06-30
RTW Investments, LP7,426,471$30.9Munchanged2026-06-30
Vanguard Capital Management LLC4,584,533$19.1Mincrease2026-06-30
Federated Hermes3,112,561$12.9Mincrease2026-06-30
State Street2,928,020$12.2Mincrease2026-06-30
Geode Capital Management, LLC2,622,888$10.9Mincrease2026-06-30
Samsara BioCapital, LLC2,500,000$10.4Munchanged2026-06-30
Bank of America1,668,423$6.9Mdecrease2026-06-30
Sio Capital Management, LLC1,486,175$6.2Mdecrease2026-06-30
Propel Bio Management, LLC1,442,397$6.0Mnew2026-06-30
Two Sigma Investments, LP1,281,227$5.3Mincrease2026-06-30
Nuveen, LLC1,215,225$5.1Mincrease2026-06-30
Barclays1,051,639$4.9Mincrease2026-09-30

Aquestive Therapeutics' latest quarter

Aquestive Therapeutics, Q3 2026: revenue $7.6M (-41% year over year), operating margin -191.5%, net loss $16.5M, operating cash flow −$7.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most AQST stock?

By the latest 13F filings: Bratton Capital Management, L.P. ($45.4M); Vanguard Group ($38.1M); BlackRock ($33.6M); RTW Investments, LP ($30.9M); Vanguard Capital Management LLC ($19.1M).

What is the short interest in AQST?

27,597,742 shares were sold short at the 2026-10-15 settlement, -4.0% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.